{"id":1105,"date":"2018-05-18T06:49:00","date_gmt":"2018-05-18T06:49:00","guid":{"rendered":"https:\/\/www.ub.edu\/creatio\/wp\/?post_type=actualitat&#038;p=1105"},"modified":"2022-10-05T07:33:25","modified_gmt":"2022-10-05T07:33:25","slug":"entrevistacanals","status":"publish","type":"actualitat","link":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/","title":{"rendered":"ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades)"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" data-src=\"https:\/\/www.ub.edu\/creatio\/wp\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165.png\" alt=\"Entrevista Dr. Canals_Ter\u00e0pies Avan\u00e7ades\" class=\"wp-image-1106 lazyload\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" style=\"--smush-placeholder-width: 1024px; --smush-placeholder-aspect-ratio: 1024\/165;\" \/><noscript><img decoding=\"async\" src=\"https:\/\/www.ub.edu\/creatio\/wp\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165.png\" alt=\"Entrevista Dr. Canals_Ter\u00e0pies Avan\u00e7ades\" class=\"wp-image-1106\"\/><\/noscript><\/figure>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Quina \u00e9s la teva funci\u00f3 actual a ADVANCE(CAT) i com valoraries aquesta experi\u00e8ncia? <\/strong><\/h4>\n\n\n\n<p>La meva funci\u00f3 \u00e9s la de coordinar, ADVANCE(CAT) reuneix 18 institucions diferents que han decidit unir esfor\u00e7os per accelerar el desenvolupament de Medicaments de Ter\u00e0pia Avan\u00e7ada (en angl\u00e8s <em>Advanced Therapy Medicinal Products<\/em>, ATMP). Tanta quantitat de socis amb una gran diversitat d&#8217;estatus jur\u00eddics i missions, des de la universitat fins a la fundaci\u00f3 privada de recerca, des de la gran farmac\u00e8utica fins a la start-up, requereix molt de treball en el vessant de la gesti\u00f3 pura per afavorir el treball col\u00b7laboratiu, alinear objectius, assegurar que tothom lliura els resultats a temps o corregeix les fites previstes. La meva funci\u00f3 \u00e9s essencialment la d&#8217;enlla\u00e7 entre les persones, d&#8217;entendre la seva posici\u00f3 i integrar-la en una perspectiva global. En el dia a dia, hi ha moltes reunions, correus electr\u00f2nics i trucades telef\u00f2niques. Tamb\u00e9 estic involucrat en el treball cient\u00edfic del meu laboratori de recerca sobre manipulaci\u00f3 de c\u00e8l\u00b7lules mare i producci\u00f3 de Bones Pr\u00e0ctiques de Fabricaci\u00f3 (en angl\u00e8s <em>Good Manufacturing Practice<\/em>s, GMP). L&#8217;experi\u00e8ncia com a coordinador \u00e9s agredol\u00e7a. Estic content de tenir tants cient\u00edfics importants al voltant de la mateixa taula i treballant junts, per\u00f2 d&#8217;alguna manera decebut per les limitacions que estableixen les normes administratives de la convocat\u00f2ria de projectes. <\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading\">Quins objectius o assoliments del projecte ADVANCE(CAT) t&#8217;agradaria destacar? <\/h4>\n\n\n\n<p>Sens dubte, el millor ha estat generar un sentit de comunitat per a moltes persones implicades en el desenvolupament d&#8217;ATMP a tants nivells de la cadena de desenvolupament. Veure com els cient\u00edfics interactuen, intercanvien idees, inicien col\u00b7laboracions, milloren els seus resultats i perspectives gr\u00e0cies a ADVANCE(CAT), aix\u00f2 \u00e9s una vict\u00f2ria. Per concretar alguns dels assoliments:<\/p>\n\n\n\n<p>Moltes institucions (UB, CMRB, BMF, BST, IGTP, IDIBELL) han pogut intercanviar protocols i material relacionat amb el cultiu cel\u00b7lular (ESC, iPSC, MSC) utilitzat per a estrat\u00e8gies de ter\u00e0pia cel\u00b7lular. <\/p>\n\n\n\n<p>Algunes start-ups han tingut l&#8217;oportunitat de perfeccionar o desenvolupar eines per a la recerca: programari (Butler) per a l&#8217;an\u00e0lisi de dades complexes i maquinari (Qrem) per a la manipulaci\u00f3 cel\u00b7lular. <\/p>\n\n\n\n<p>Els socis industrials (Ferrer, Bioib\u00e9rica) han aportat estudis crucials sobre el mercat i la propietat intel\u00b7lectual per ajudar a triar les estrat\u00e8gies de desenvolupament adequades i aix\u00ed,  assegurar un futur per als ATMP.<\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading\">Quines s\u00f3n les vostres expectatives del projecte ADVANCE(CAT)? <\/h4>\n\n\n\n<p>Principalment, el coneixement de qui est\u00e0 en ATMP arreu de Catalunya i tota l&#8217;experi\u00e8ncia disponible facilitaran el cam\u00ed per al desenvolupament. Esperem que ADVANCE(CAT) continu\u00ef en el futur, tamb\u00e9 estem treballant en aquest aspecte, i esperem que sigui el punt de trobada dels especialistes d&#8217;ATMP per generar solucions per als pacients alhora que es crea una ind\u00fastria amb un alt impacte en l&#8217;economia local. <\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading\">Qu\u00e8 tan positiu \u00e9s que durant la propera d\u00e8cada avan\u00e7arem de manera significativa en termes de ter\u00e0pies avan\u00e7ades? <\/h4>\n\n\n\n<p>Ja fa 10 anys que la UE va regular per primera vegada l&#8217;\u00fas d&#8217;ATMP. Com que es basen en manipulacions biol\u00f2giques complexes, els ATMP han lluitat molt per aportar millores constants per a la salut dels pacients respecte a l&#8217;est\u00e0ndard d&#8217;atenci\u00f3 i ser sostenibles com a ind\u00fastria. Els propers 10 anys seran crucials per consolidar el camp. Necessitem regulacions harmonitzades per a tota la Uni\u00f3 Europea i un aven\u00e7 tecnol\u00f2gic per fer que els ATMP siguin m\u00e9s avantguardistes i m\u00e9s barats. \u00c9s un cam\u00ed complicat per\u00f2 prometedor.<\/p>\n","protected":false},"author":1,"featured_media":1724,"template":"","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades) - Creatio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades) - Creatio\" \/>\n<meta property=\"og:description\" content=\"Quina \u00e9s la teva funci\u00f3 actual a ADVANCE(CAT) i com valoraries aquesta experi\u00e8ncia? La meva funci\u00f3 \u00e9s la de coordinar, ADVANCE(CAT) reuneix 18 institucions diferents que han decidit unir esfor\u00e7os per accelerar el desenvolupament de Medicaments de Ter\u00e0pia Avan\u00e7ada (en angl\u00e8s Advanced Therapy Medicinal Products, ATMP). Tanta quantitat de socis amb una gran diversitat d&#8217;estatus [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/\" \/>\n<meta property=\"og:site_name\" content=\"Creatio\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-05T07:33:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"165\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Creatio_UB\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/\",\"url\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/\",\"name\":\"ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades) - Creatio\",\"isPartOf\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165-1.png\",\"datePublished\":\"2018-05-18T06:49:00+00:00\",\"dateModified\":\"2022-10-05T07:33:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#primaryimage\",\"url\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165-1.png\",\"contentUrl\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165-1.png\",\"width\":1024,\"height\":165},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.ub.edu\/creatio\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/#website\",\"url\":\"https:\/\/www.ub.edu\/creatio\/\",\"name\":\"Creatio\",\"description\":\"Production and validation center of advanced therapies\",\"publisher\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ub.edu\/creatio\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/#organization\",\"name\":\"Creatio\",\"url\":\"https:\/\/www.ub.edu\/creatio\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2021\/12\/creatio-logo.png\",\"contentUrl\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2021\/12\/creatio-logo.png\",\"width\":698,\"height\":110,\"caption\":\"Creatio\"},\"image\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/Creatio_UB\",\"https:\/\/www.linkedin.com\/company\/creatio-ub\",\"https:\/\/www.instagram.com\/creatio.ub\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades) - Creatio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/","og_locale":"es_ES","og_type":"article","og_title":"ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades) - Creatio","og_description":"Quina \u00e9s la teva funci\u00f3 actual a ADVANCE(CAT) i com valoraries aquesta experi\u00e8ncia? La meva funci\u00f3 \u00e9s la de coordinar, ADVANCE(CAT) reuneix 18 institucions diferents que han decidit unir esfor\u00e7os per accelerar el desenvolupament de Medicaments de Ter\u00e0pia Avan\u00e7ada (en angl\u00e8s Advanced Therapy Medicinal Products, ATMP). Tanta quantitat de socis amb una gran diversitat d&#8217;estatus [&hellip;]","og_url":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/","og_site_name":"Creatio","article_modified_time":"2022-10-05T07:33:25+00:00","og_image":[{"width":1024,"height":165,"url":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@Creatio_UB","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/","url":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/","name":"ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades) - Creatio","isPartOf":{"@id":"https:\/\/www.ub.edu\/creatio\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#primaryimage"},"image":{"@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165-1.png","datePublished":"2018-05-18T06:49:00+00:00","dateModified":"2022-10-05T07:33:25+00:00","breadcrumb":{"@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#primaryimage","url":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165-1.png","contentUrl":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2018\/05\/Entrevista-Dr.-Canals_Terapies-Avancades-1024x165-1.png","width":1024,"height":165},{"@type":"BreadcrumbList","@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/entrevistacanals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ub.edu\/creatio\/"},{"@type":"ListItem","position":2,"name":"ADVANCE(CAT) Dr. Canals (Ter\u00e0pies Avan\u00e7ades)"}]},{"@type":"WebSite","@id":"https:\/\/www.ub.edu\/creatio\/#website","url":"https:\/\/www.ub.edu\/creatio\/","name":"Creatio","description":"Production and validation center of advanced therapies","publisher":{"@id":"https:\/\/www.ub.edu\/creatio\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ub.edu\/creatio\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ub.edu\/creatio\/#organization","name":"Creatio","url":"https:\/\/www.ub.edu\/creatio\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ub.edu\/creatio\/#\/schema\/logo\/image\/","url":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2021\/12\/creatio-logo.png","contentUrl":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2021\/12\/creatio-logo.png","width":698,"height":110,"caption":"Creatio"},"image":{"@id":"https:\/\/www.ub.edu\/creatio\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Creatio_UB","https:\/\/www.linkedin.com\/company\/creatio-ub","https:\/\/www.instagram.com\/creatio.ub\/"]}]}},"lang":"ca","translations":{"ca":1105,"es":1108,"en":1110},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/actualitat\/1105"}],"collection":[{"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/actualitat"}],"about":[{"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/types\/actualitat"}],"author":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/media\/1724"}],"wp:attachment":[{"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/media?parent=1105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}